Home/Filings/4/0001390478-15-000005
4//SEC Filing

Galena Biopharma, Inc. 4

Accession 0001390478-15-000005

$SLSCIK 0001390478operating

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 7:38 PM ET

Size

7.6 KB

Accession

0001390478-15-000005

Insider Transaction Report

Form 4
Period: 2015-01-16
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
  • Other

    Common Stock

    2014-12-31$1.28/sh+3,846$4,923415,972 total
  • Award

    Stock Option (right to buy)

    2015-01-16+550,000550,000 total
    Exercise: $1.75Exp: 2025-01-16Common Stock (550,000 underlying)
Footnotes (3)
  • [F1]Pursuant to the Issuer's Employee Stock Purchase Plan.
  • [F2]Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.
  • [F3]The option will vest in 16 equal quarterly installments of 34,375 shares over four years beginning on the first quarterly anniversary of the grant date (i.e., January 16, 2015), provided, in each case, that the Reporting Person remains in the continuous employ of the Issuer through such quarterly anniversary date.

Issuer

Galena Biopharma, Inc.

CIK 0001390478

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001390478

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 7:38 PM ET
Size
7.6 KB